Flex Ltd. (FLEX)

bluebird bio Stock Forecast

Stock Price Forecast

The 9 analysts that cover bluebird bio stock have a consensus rating of "Strong Buy" and an average price target of $52, which forecasts a 2.08% increase in the stock price over the next year. The lowest target is $41 and the highest is $60.

Price Target: $52.00 (+2.08%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$41	$52	$52	$60
Change	-19.51%	+2.08%	+2.08%	+17.79%

Analyst Ratings

The average analyst rating for bluebird bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	5	5	5	5	5	5
Buy	3	3	3	4	4	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ruben Roy Stifel	Stifel	Strong Buy Maintains $45 → $52	Strong Buy	Maintains	$45 → $52	+2.08%	Jul 25, 2025
George Wang Barclays	Barclays	Buy Maintains $50 → $60	Buy	Maintains	$50 → $60	+17.79%	Jul 25, 2025
Samik Chatterjee JP Morgan	JP Morgan	Buy Maintains $44 → $60	Buy	Maintains	$44 → $60	+17.79%	Jul 17, 2025
Ruplu Bhattacharya B of A Securities	B of A Securities	Strong Buy Maintains $50 → $58	Strong Buy	Maintains	$50 → $58	+13.86%	Jul 10, 2025
Steve Barger Keybanc	Keybanc	Buy Maintains $50 → $60	Buy	Maintains	$50 → $60	+17.79%	Jul 2, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

27.05B

Increased by 4.81%

from 25.81B

Revenue Next Year

28.23B

Increased by 4.36%

from 27.05B

EPS This Year

3.00

Increased by 42.22%

from 2.11

EPS Next Year

3.36

Increased by 11.94%

from 3.00

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027	Mar 31, 2028
Revenue	24.12B	24.63B	28.50B	26.42B	25.81B	27.05B	28.23B	30.01B
Revenue Growth	-0.36%	2.11%	15.71%	-7.32%	-2.28%	4.81%	4.36%	6.31%
EPS	1.21	1.94	1.72	2.28	2.11	3.00	3.36	3.52
EPS Growth	611.77%	60.33%	-11.34%	32.56%	-7.46%	42.22%	11.94%	4.76%
Forward PE	-	-	-	-	-	16.98	15.16	14.48
No. Analysts	-	-	-	-	-	12	11	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	28.3B	30.3B	31.9B
Avg	27.1B	28.2B	30.0B
Low	25.5B	26.5B	28.1B

Revenue Growth

Revenue Growth	2026	2027	2028
High	9.7%	12.0%	12.8%
Avg	4.8%	4.4%	6.3%
Low	-1.3%	-2.2%	-0.4%

EPS Forecast

EPS	2026	2027	2028
High	3.22	3.61	3.62
Avg	3.00	3.36	3.52
Low	2.79	3.14	3.38

EPS Growth

EPS Growth	2026	2027	2028
High	52.8%	20.4%	7.8%
Avg	42.2%	11.9%	4.8%
Low	32.4%	4.5%	0.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.